Cornelius P. McCarthy, III net worth and biography

Cornelius McCarthy, III Biography and Net Worth

Director of Medpace

Mr. McCarthy has served as the Managing Director and CEO of Fairmount Partners since 2003 and focuses primarily on healthcare and pharmaceutical outsourced services. Prior to founding Fairmount Partners, Mr. McCarthy was Vice President, Managing Director and Head of US Investment Banking at PMG/Investec from 1997 to 2003. Prior to 1997, Mr. McCarthy held a number of legal and investment banking roles. Mr. McCarthy is currently a Director of Atlantic Research Services, LLC and NMS Laboratories, Inc. Additionally, from 2006 to 2013 he was a Director of predecessor entities of the Company.

Mr. McCarthy received his undergraduate degree from the University of Virginia where he was an Echols Scholar and his JD from Villanova Law School. Mr. McCarthy was chosen as a director because of his significant investment and financial experience, his experience in the CRO industry and his experience serving on boards.

What is Cornelius P. McCarthy, III's net worth?: The estimated net worth of Cornelius P. McCarthy, III is at least $5.56 million as of August 19th, 2025. Mr. McCarthy, III owns 10,197 shares of Medpace stock worth more than $5,555,020 as of December 5th. This net worth approximation does not reflect any other investments that Mr. McCarthy, III may own. Learn More about Cornelius P. McCarthy, III's net worth.
How do I contact Cornelius P. McCarthy, III?: The corporate mailing address for Mr. McCarthy, III and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on Cornelius P. McCarthy, III's contact information.
Has Cornelius P. McCarthy, III been buying or selling shares of Medpace?: Cornelius P. McCarthy, III has not been actively trading shares of Medpace during the last quarter. Most recently, Cornelius P. Mccarthy III sold 1,662 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $465.04, for a transaction totalling $772,896.48. Following the completion of the sale, the director now directly owns 10,197 shares of the company's stock, valued at $4,742,012.88. Learn More on Cornelius P. McCarthy, III's trading history.
Who are Medpace's active insiders?: Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Fred Davenport, Jr. (Director), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), Cornelius McCarthy, III (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.
Are insiders buying or selling shares of Medpace?: In the last twelve months, Medpace insiders bought shares 1 times. They purchased a total of 2 shares worth more than $652.22. In the last twelve months, insiders at the sold shares 34 times. They sold a total of 550,903 shares worth more than $308,014,789.86. The most recent insider tranaction occured on December, 3rd when CEO August J Troendle sold 668 shares worth more than $394,580.92. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.
Information on this page was last updated on 12/3/2025.

Cornelius P. McCarthy, III Insider Trading History at Medpace

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/19/2025	Sell	1,662	$465.04	$772,896.48	10,197

Cornelius P. McCarthy, III Buying and Selling Activity at Medpace

Medpace Company Overview

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Today's Range

Now: $544.77

$530.96

$576.29

50 Day Range

MA: $566.87

$496.79

$618.49

2 Week Range

Now: $544.77

$250.05

$626.26

Volume

580,054 shs

Average Volume

248,524 shs

Market Capitalization

$15.35 billion

P/E Ratio

38.10

Dividend Yield

N/A

Beta

1.43